Antimicrobial Resistance Collaborators. Global burden of bacterial antimicrobial resistance in 2019: a systematic analysis. Lancet, 2022; 399(10325): 629–655. DOI: 10.1016/S0140-6736(21)02724-0.
2.
StrathdeeSA, HatfullGF, MutalikVK, SchooleyRT. Phage therapy: From biological mechanisms to future directions. Cell, 2023; 186(1): 17–31. DOI: 10.1016/j.cell.2022.11.017.
3.
DelattreR, SeuratJ, HaddadF, et al.Combination of in vivo phage therapy data with in silico model highlights key parameters for pneumonia treatment efficacy. Cell Rep. 2022; 39(7): 110825. DOI: 10.1016/j.celrep.2022.110825.
4.
RotmanSG, PostV, FosterAL, et al.Alginate chitosan microbeads and thermos-responsive hyaluronic acid hydrogel for phage delivery. J. Drug Deliv. Sci. Technol., 2023; 79: 103991. DOI: 10.1016/j.jddst.2022.103991.
DialloK, DublanchetA. Benefits of Combined Phage-Antibiotic Therapy for the Control of Antibiotic-Resistant Bacteria: A Literature Review. Antibiotics (Basel), 2022; 11(7): 839. DOI: 10.3390/antibiotics11070839.
8.
AkturkE, MeloLDR, OliveiraH, et al.Combining phages and antibiotic to enhance antibiofilm efficacy against an in vitro dual species wound biofilm. Biofilm, 2023; 6: 100147. DOI: 10.1016/j.bioflm.2023.100147.
9.
NikolicI, VukovicD, GavricD, et al.An Optimized Checkerboard Method for Phage-Antibiotic Synergy Detection. Viruses, 2022; 14(7): 1542. DOI: 10.3390/v14071542.
10.
FabijanAP, LinRCY, HoJ. Safety of bacteriophage therapy in severe Staphylococcus aureus infection. Nat. Microbiol., 2020; 5(3): 465–472. DOI: 10.1038/s41564-019-0634-z.
11.
GuanJ, Oromí-BoschA, MendozaSD, et al.Bacteriophage genome engineering with CRISPR-Cas13a. Nat. Microbiol. 2022; 7(12): 1956–1966. DOI: 10.1038/s41564-022-01243-4.
